Acne

With acne presenting in increasingly younger patients, new guidelines developed by the American Acne and Rosacea Society (AARS) promote more consistent care for pediatric patients, according to an expert.

While topical and oral therapies remain the gold standard approach for treating acne, laser and light sources are effective for acne lesions and scarring, and can be particularly useful in cases recalcitrant to standard therapeutic approaches.

Recent developments regarding acne and rosacea in skin of color include studies showing that combination topical products for acne appear safe in this population, and the fact that rosacea is perhaps more prevalent than many might expect.

Clinicians can sift facts from fiction on diseases such as acne by checking Twitter, a letter by Boston-based Center for Connected Health researchers suggests.

Newly released expert recommendations from the American Acne and Rosacea Society are the first evidence-based clinical guidelines for the management of acne vulgaris in children and adolescents.

Promius Pharma has launched Zenatane (isotretinoin) capsules for the treatment of acne vulgaris.

Dermatologists’ prescribing of oral contraceptive pills (OCPs) and antibiotics for acne leaves room for improvement, according to an expert.

The Food and Drug Administration has approved the topical acne drug Epiduo (adapalene 01. percent/benzoyl peroxide 2.5 percent, Galderma) in children ages 9 and older, according to a news release.

Acne scars are potentially socially debilitating lifelong reminders of the condition. Fortunately, modern laser therapy allows dermatologists to offer their patients hope for improvement. Prior to initiating laser therapy for acne scars it is important to consider the types of scars encountered.

A microneedle radiofrequency (RF) device was as effective for acne vulgaris as a carbon dioxide (CO2) laser, but with less downtime, according to findings from a recent study.

Revolutionized by the advent of fractional laser technology, laser surgery for scars continues to evolve. However, clinicians continue to be confronted with a wide variety of scar types without a well-established treatment algorithm.

Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.

Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology and Venereology suggest.

A new study involving cross-sectional samples of the U.S. population reveals no association between isotretinoin and suicidality, the study-s author says.